Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

ACHV

Achieve Life Sciences Inc.

Apr 17 • 04:00PM ET

4.57

Dollar change +0.19
Percentage change 4.34	%

Healthcare • Biotechnology • Canada • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF SURI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.53	Insider Own	15.23%	Shs Outstand	34.25M	Perf Week	4.34%
Market Cap	156.52M	Forward P/E	-	EPS next Y	-1.00	Insider Trans	0.38%	Shs Float	29.03M	Perf Month	-0.65%
Income	-29.82M	PEG	-	EPS next Q	-0.24	Inst Own	19.81%	Short Float	2.47%	Perf Quarter	5.79%
Sales	0.00M	P/S	-	EPS this Y	27.89%	Inst Trans	1.44%	Short Ratio	7.25	Perf Half Y	20.90%
Book/sh	-0.07	P/B	-	EPS next Y	7.55%	ROA	-120.85%	Short Interest	0.72M	Perf Year	-41.41%
Cash/sh	0.45	P/C	10.07	EPS next 5Y	15.00%	ROE	-869.88%	52W Range	3.03 - 10.30	Perf YTD	10.92%
Dividend Est.	-	P/FCF	-	EPS past 5Y	53.91%	ROI	-	52W High	-55.63%	Beta	1.27
Dividend TTM	-	Quick Ratio	0.82	Sales past 5Y	0.00%	Gross Margin	-	52W Low	50.83%	ATR (14)	0.22
Dividend Ex-Date	-	Current Ratio	0.82	EPS Y/Y TTM	62.37%	Oper. Margin	0.00%	RSI (14)	55.48	Volatility	4.23% 4.80%
Employees	22	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	19.29
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	68.82%	Payout	-	Rel Volume	0.52	Prev Close	4.38
Sales Surprise	-	EPS Surprise	16.13%	Sales Q/Q	-	Earnings	Mar 28 AMC	Avg Volume	98.99K	Price	4.57
SMA20	1.48%	SMA50	3.60%	SMA200	-0.78%	Trades		Volume	51,903	Change	4.34%

Date	Action	Analyst	Rating Change	Price Target Change
May-10-23	Reiterated	Maxim Group	Buy	$8 → $20
Jun-23-21	Initiated	Oppenheimer	Outperform	$23

Apr-11-24 08:00AM	Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference (GlobeNewswire)
Apr-01-24 03:30PM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-29-24 06:24AM	Q4 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-28-24 08:53PM	ACHV Stock Earnings: Achieve Life Sciences Beats EPS for Q4 2023 (InvestorPlace)
05:32PM	Achieve Life Sciences Inc Reports Year-End Loss, Progresses Towards FDA Approval (GuruFocus.com)
04:01PM	Loading…
04:01PM	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update (GlobeNewswire)
Mar-20-24 08:00AM	Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting (GlobeNewswire)
Mar-14-24 08:00AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024 (GlobeNewswire)
Mar-08-24 08:35AM	Life Science Virtual Investor Forum Presentations Now Available for Online Viewing (GlobeNewswire)
Mar-06-24 08:00AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Mar-05-24 08:35AM	Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024 (GlobeNewswire)
Feb-29-24 08:01AM	Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission (GlobeNewswire) -9.19%
08:00AM	Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire)
Dec-15-23 08:35AM	Life Science Investor Forum: Presentations Now Available for Online Viewing (GlobeNewswire)
Dec-13-23 08:00AM	TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors (GlobeNewswire) +5.40%
01:02PM	Loading…
Dec-12-23 01:02PM	Life Science Investor Forum Agenda Announced for December 14th, 2023 (GlobeNewswire) -42.20%
09:10AM	Why Is Achieve Life Sciences (ACHV) Stock Down 25% Today? (InvestorPlace)
Dec-11-23 04:30PM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Nov-11-23 10:36AM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 10:01AM	Q3 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-09-23 04:00PM	Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update (GlobeNewswire)
Oct-26-23 08:00AM	Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023 (GlobeNewswire)
Oct-03-23 08:00AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Sep-11-23 08:00AM	Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting (GlobeNewswire)
Sep-07-23 08:00AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire) -5.24%
Aug-16-23 10:30AM	ACHV: 2Q:23 Results (Zacks)
Aug-15-23 10:25PM	Q2 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-14-23 04:00PM	Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update (GlobeNewswire)
Aug-01-23 08:00AM	Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast (GlobeNewswire)
Jul-18-23 08:00AM	Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual Meeting (GlobeNewswire)
11:23AM	Loading…
Jul-11-23 11:23AM	Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA) (GlobeNewswire)
May-25-23 09:00AM	Achieve Life Sciences Announces Pricing of $16.5 Million Registered Direct Offering (GlobeNewswire) -6.07%
07:16AM	ACHV: ORCA-3 Topline (Zacks Small Cap Research)
May-24-23 06:10AM	Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) Shift From Loss To Profit (Simply Wall St.)
May-23-23 02:46PM	Can't Kick the Bud? Achieve's Cytisinicline Proves Promising in Phase 3 Smoking Cessation Trial (Benzinga) -23.80%
06:00AM	Achieve Life Sciences Reports Statistically Significant Smoking Cessation Benefit for Cytisinicline in Second, Confirmatory Phase 3 Clinical Trial (GlobeNewswire)
May-17-23 08:00AM	Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank (GlobeNewswire)
May-10-23 09:08AM	ACHV: First Quarter Results (Zacks Small Cap Research) +12.71%
05:57AM	Q1 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
May-09-23 04:05PM	Achieve Life Sciences Reports Financial Results for First Quarter 2023 and Provides Corporate Update (GlobeNewswire)
Apr-26-23 08:00AM	Achieve Life Sciences to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 9, 2023 (GlobeNewswire)
Apr-24-23 05:27AM	ACHV: ORCA-V1 Readout (Zacks Small Cap Research)
Apr-20-23 02:22PM	Want To Quit Smoking? Achieve Life Sciences Reports Successful E-Cigarette Cessation Benefit With Cytisinicline Treatment (Benzinga)
08:00AM	Achieve Life Sciences Announces Positive Phase 2 ORCA-V1 Trial Results Showing Statistically Significant Vaping Cessation Benefit for Participants Treated with Cytisinicline (GlobeNewswire)
Apr-14-23 08:00AM	Achieve Life Sciences to Present at Life Science Innovation Northwest 2023 Conference (GlobeNewswire)
Mar-30-23 08:00AM	Achieve Life Sciences Announces Refresh to Board of Directors (GlobeNewswire) +5.86%
Mar-29-23 08:00AM	Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation (GlobeNewswire) +7.57%
Mar-20-23 10:46PM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2022 Earnings Call Transcript (Insider Monkey)
05:27AM	ACHV: 2022 Financial and Operational Results (Zacks Small Cap Research)
Mar-17-23 08:00AM	Achieve Life Sciences Announces Granting of New Hire Inducement Award (GlobeNewswire)
05:48AM	Q4 2022 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-16-23 04:05PM	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2022 and Provides Corporate Update (GlobeNewswire)
Mar-08-23 08:00AM	Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation (GlobeNewswire)
Mar-03-23 08:00AM	Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting (GlobeNewswire) +7.79%
Mar-02-23 08:00AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023 (GlobeNewswire)
Feb-15-23 05:42AM	Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) top owners are individual investors with 56% stake, while 43% is held by institutions (Simply Wall St.) -15.52%
Feb-07-23 08:00AM	Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation (GlobeNewswire)
Feb-02-23 08:00AM	Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-27-23 04:30PM	Achieve Life Sciences Announces Granting of New Hire Inducement Award (GlobeNewswire)
Jan-09-23 08:00AM	Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation (GlobeNewswire) +7.28%
Dec-29-22 06:02AM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2022 Earnings Call Transcript (Insider Monkey)
Dec-21-22 08:00AM	Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation (GlobeNewswire)
Nov-21-22 06:01AM	ACHV: 3Q:22 Results: Target Enrollments Reached (Zacks Small Cap Research)
Nov-15-22 08:00AM	Achieve Life Sciences Announces Private Placement of $18.9 Million (GlobeNewswire) +5.45%
Nov-14-22 04:05PM	Achieve Reports Financial Results for Third Quarter 2022 and Provides Corporate Update (GlobeNewswire)
Nov-08-22 08:00AM	Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial (GlobeNewswire)
Oct-31-22 08:00AM	Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022 (GlobeNewswire)
Sep-27-22 08:00AM	Achieve Announces Completion of Target Enrollment in the Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation (GlobeNewswire) -7.42%
Sep-07-22 08:00AM	Achieve Life Sciences Announces Participation at Fall Investor Conferences (GlobeNewswire)
Aug-15-22 06:16AM	ACHV: Autumn Enrollment Completion for ORCA-3 (Zacks Small Cap Research) +12.80%
Aug-11-22 04:05PM	Achieve Reports Financial Results for Second Quarter 2022 and Provides Corporate Update (GlobeNewswire)
Jul-28-22 08:00AM	Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 11, 2022 (GlobeNewswire)
Jul-01-22 04:05PM	Achieve Life Sciences Announces Granting of New Hire Inducement Awards (GlobeNewswire)
Jun-29-22 08:00AM	Achieve Life Sciences Announces Initiation of Phase 2 ORCA-V1 Clinical Trial Evaluating Cytisinicline for Nicotine e-cigarette Cessation (GlobeNewswire)
Jun-21-22 08:00AM	Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference (GlobeNewswire)
Jun-01-22 08:00AM	Achieve Life Sciences Awarded Grant from the National Institutes of Health to Conduct Phase 2 Trial of Cytisinicline in Nicotine e-cigarette Users (GlobeNewswire)
May-26-22 08:00AM	Achieve Life Sciences Announces Participation at LD Micro Invitational Conference (GlobeNewswire)
May-16-22 01:20PM	36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 (ACCESSWIRE)
May-13-22 08:00AM	Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference (GlobeNewswire)
06:30AM	ACHV: First Quarter 2022 Results (Zacks Small Cap Research)
May-12-22 04:00PM	Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update (GlobeNewswire)
May-05-22 02:59PM	Health Check: How Prudently Does Achieve Life Sciences (NASDAQ:ACHV) Use Debt? (Simply Wall St.)
Apr-28-22 05:22AM	ACHV: Topline Data from ORCA-2 Smoking Cessation Trial (Zacks Small Cap Research) -6.46%
Apr-27-22 09:40AM	Achieve Life Sciences Aces Pivotal Cytisinicline Study In Smoking Cessation (Benzinga) +7.68%
08:00AM	Achieve Life Sciences Announces Successful, Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers (GlobeNewswire)
Apr-21-22 08:00AM	Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 12, 2022 (GlobeNewswire)
Mar-15-22 08:00AM	Achieve Life Sciences Announces Cytisinicline Presentation at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting (GlobeNewswire)
Mar-14-22 08:00AM	Achieve Life Sciences Announces Appointment of Dr. Vaughn Himes to Board of Directors (GlobeNewswire)
Mar-11-22 08:06AM	ACHV: 2021 Results: ORCA-3 Underway, ORCA-V1 Soon to Start (Zacks Small Cap Research)
08:00AM	Achieve Life Sciences Announces Expansion of Manufacturing & Quality Operations Team and Granting of Inducement Award (GlobeNewswire)
Mar-10-22 08:00AM	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2021 and Provides Corporate Update (GlobeNewswire)
Mar-08-22 08:00AM	Achieve Life Sciences Announces Participation in March Investor Conferences (GlobeNewswire)
Feb-24-22 08:00AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2021 Financial Results and Host Conference Call and Webcast on March 10, 2022 (GlobeNewswire)
Feb-04-22 04:37AM	ACHV: The Final Phase III Begins (Zacks Small Cap Research)
Feb-03-22 08:00AM	Achieve Life Sciences Announces Expansion of Cytisinicline Clinical Operations Team and Granting of Inducement Award (GlobeNewswire)
Feb-02-22 08:00AM	Achieve Life Sciences Announces Participation in February Investor Conferences (GlobeNewswire)
Jan-28-22 10:07AM	36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022 (ACCESSWIRE)
Jan-25-22 11:08AM	Achieve Life Sciences Initiates Pivotal Trial Of Cytisinicline For Smoking Cessation (Benzinga)
08:00AM	Achieve Life Sciences Announces Initiation of the Phase 3 ORCA-3 Clinical Trial Evaluating Cytisinicline for Smoking Cessation (GlobeNewswire)
Jan-06-22 08:30AM	Achieve Life Sciences to Present at H.C. Wainwright BIOCONNECT Virtual Conference (GlobeNewswire)

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stewart Richard Alistair	Executive Chairman	Mar 04 '24	Buy	4.58	10,000	45,850	38,501	Mar 06 04:49 PM
Bencich John	CEO	Mar 04 '24	Buy	4.58	10,000	45,850	76,724	Mar 06 04:43 PM
Bencich John	CEO	May 30 '23	Buy	5.50	5,000	27,500	66,730	Jun 01 05:42 PM
JACOBS CINDY	President & CMO	Apr 28 '23	Option Exercise	0.00	2,500	0	18,870	May 01 05:54 PM
Wan Jerry	Principal Accounting Officer	Apr 28 '23	Option Exercise	0.00	1,250	0	7,101	May 01 05:55 PM
Bencich John	CEO	Apr 28 '23	Option Exercise	0.00	7,500	0	63,557	May 01 05:53 PM
Stewart Richard Alistair	Executive Chairman	Apr 28 '23	Option Exercise	0.00	5,000	0	30,751	May 01 05:51 PM
Wan Jerry	Principal Accounting Officer	Apr 21 '23	Option Exercise	0.00	5,625	0	8,861	Apr 24 04:17 PM
Stewart Richard Alistair	Executive Chairman	Apr 21 '23	Option Exercise	0.00	22,500	0	35,876	Apr 24 04:15 PM
JACOBS CINDY	President & CMO	Apr 21 '23	Option Exercise	0.00	16,250	0	20,181	Apr 24 04:14 PM
Bencich John	CEO	Apr 21 '23	Option Exercise	0.00	25,000	0	61,920	Apr 24 04:13 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACHV

Achieve Life Sciences Inc.

Upgrade your FINVIZ experience